January 19, 2018
Partap Khalsa, D.C., Ph.D.
On Friday, February 9, the National Advisory Council for Complementary and Integrative Health (NACCIH) will hold its second meeting of Fiscal Year 2018. NCCIH grantees, potential applicants, and others may find it useful to hear updates on the Center’s activities, policies, and funding priorities. We will provide a livestream of the meeting’s open session via NIH Videocast from 10:00 a.m. to 3:05 p.m. ET. Our agenda includes a panel focused on clinical trials.
January 26, 2018
Martina Schmidt, Ph.D.
Have you considered an administrative scientific career at the National Institutes of Health (NIH)? At NCCIH, you can impact research in diverse areas, such as nonpharmacologic management of pain, the neurobiological effects and mechanisms of complementary and integrative therapies, exploration of innovative approaches for establishing biological signatures of natural products, disease prevention and health promotion across the lifespan, or clinical trials utilizing innovative study designs to assess complementary health approaches and their integration into health care? The peer review process is one of the cornerstones that allows NIH to accomplish its extramural mission by ensuring that applications submitted to NIH are evaluated by scientific experts in a manner that is free from inappropriate influences.
You may be tempted by the “quick fix” claims of dietary supplements for losing weight, bodybuilding, or sexual enhancement products. Available in supermarkets, pharmacies, health food stores, and on the Internet, most of these products haven’t been proven safe or effective. Safety concerns about natural products include the possibility of drug interactions, direct toxicities, and contamination of supplements with active pharmaceutical agents. Although there is a widespread public perception that the botanical and traditional agents included in dietary supplements can be viewed as safe, it is abundantly clear that these products carry the same dangers as other pharmacologically active compounds.
The NIH All of Us Research Program is soliciting ideas for important research questions to address over the next decade, to help make our data platform as useful as possible for the many communities. All of Us is designed to be a broad public resource to accelerate precision medicine. We want your input to help us determine the most critical types of data to collect and how, so we can build a research platform capable of supporting thousands of studies across NIH's research areas.
Borrowing a requirements gathering process from Silicon Valley, we are accepting research ideas--or "use cases"--through February 23 on the IdeaScale platform, where you also may view and comment on others' suggestions. Please send us your thoughts and share this with anyone you know outside of NIH who may be interested.
Resources for Researchers
NCCIH encourages innovative technological research and development of commercializable products that will fulfill NCCIH’s mission. Applications may include basic, preclinical, and early phase clinical studies.
- PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) PA‑18‑576
- PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) PA‑18‑573
- PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA‑18‑574
- PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) PA‑18‑575
NCCIH partially supports these scientific meeting through the R13 award.
- 02/07/18 -- Teaching Kitchen Collaborative Research Day 2018
- 03/04/18 -- Innovations in Marine Natural Products Research: From Discovery to Application
February 8, 2018, 11 a.m. ET; NIH Main Campus, Bethesda, MD (in-person attendance only).
February 9, 2018, NIH Main Campus, Bethesda, MD (will be videocast). Agenda now posted.